Hypoalbuminemia, a significant risk factor for thrombocytopenia associated with tedizolid therapy.
- Published in:
- Research on Drug Interactions, 2023, v. 47, n. 2, p. 15
- By:
- Publication type:
- Article
Works matching IS 03855015 AND DT 2023 AND VI 47 AND IP 2
Results: 3
1
2
ネフロロジー領域におけるトピックと薬物間相互作用による腎障害.
- Published in:
- Research on Drug Interactions, 2023, v. 47, n. 2, p. 1
- By:
- Publication type:
- Article
3
ハイパーポリファーマシーに対する病棟薬剤師による介入効果.
- Published in:
- Research on Drug Interactions, 2023, v. 47, n. 2, p. 23
- By:
- Publication type:
- Article